Finance

Lists
Why is 688185 up 3,52%?
Dive Deeper
688185:SHA
Cansino Biologics Inc
CN¥85,61
+3,52%
(+2,91) 1D
16 Okt., 13:44:05 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688185...
Open
CN¥84,00
High
CN¥91,60
Low
CN¥83,88
Mkt. cap
13,64 mjd
Avg. vol.
10,80 m
Volume
9,93 m
P/E ratio
436,59
52-wk high
CN¥108,00
52-wk low
CN¥46,89
EPS
CN¥0,20
No. of employees
1 k
Open
CN¥84,00
High
CN¥91,60
Low
CN¥83,88
Mkt. cap
13,64 mjd
Avg. vol.
10,80 m
Volume
9,93 m
P/E ratio
436,59
52-wk high
CN¥108,00
52-wk low
CN¥46,89
EPS
CN¥0,20
No. of employees
1 k
News stories
From web sources and news partners
Profile
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
About Cansino Biologics Inc
CEOXuefeng Yu
Employees1,18 k
Founded13 Jan. 2009
Headquarters-
Sector-
Websitecansinotech.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
310,24 m
375,34 m
190,28 m
359,54 m
Cost of goods sold
55,37 m
129,82 m
36,26 m
97,60 m
Cost of revenue
55,37 m
129,82 m
36,26 m
97,60 m
Research and development expenses
76,87 m
88,37 m
71,41 m
84,08 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
158,60 m
187,81 m
116,85 m
158,72 m
Operating expense
218,49 m
325,84 m
182,92 m
258,68 m
Total operating expenses
273,86 m
455,66 m
219,19 m
356,28 m
Operating income
36,38 m
-80,32 m
-28,90 m
3,26 m
Other non operating income
-8,06 m
5,34 m
-9,91 m
7,97 m
EBT including unusual items
27,79 m
13,25 m
-34,38 m
40,42 m
EBT excluding unusual items
40,15 m
-74,47 m
-36,57 m
-3,72 m
Income tax expense
-134,75 k
-181,72 k
6,04 m
714,36 k
Effective tax rate
-0,48%
-1,37%
-17,58%
1,77%
Other operating expenses
-15,79 m
50,87 m
-9,21 m
12,43 m
Net income
27,93 m
13,43 m
-40,42 m
39,70 m
Net profit margin
9,00%
3,58%
-21,24%
11,04%
Earnings per share
-
-
-
-
Interest and investment income
13,97 m
21,09 m
9,43 m
12,84 m
Interest expense
-11,11 m
-3,20 m
-7,19 m
-5,91 m
Net interest expenses
2,86 m
17,88 m
2,24 m
6,92 m
Depreciation and amortization charges
-
-
-
-
EBITDA
82,74 m
-39,25 m
12,18 m
49,79 m
Gain or loss from assets sale
84,72 k
-137,05 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme